165 related articles for article (PubMed ID: 32931822)
1. Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis.
Zeder K; Avian A; Bachmaier G; Douschan P; Foris V; Sassmann T; Moazedi-Fuerst FC; Graninger WB; Hafner F; Brodmann M; Salmhofer W; Olschewski H; Kovacs G
Chest; 2021 Feb; 159(2):781-790. PubMed ID: 32931822
[TBL] [Abstract][Full Text] [Related]
2. Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients.
Hager WD; Collins I; Tate JP; Azrin M; Foley R; Lakshminarayanan S; Rothfield NF
Clin Respir J; 2013 Jul; 7(3):227-36. PubMed ID: 22789029
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
[TBL] [Abstract][Full Text] [Related]
4. Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis.
Stamm A; Saxer S; Lichtblau M; Hasler ED; Jordan S; Huber LC; Bloch KE; Distler O; Ulrich S
Eur Respir J; 2016 Dec; 48(6):1658-1667. PubMed ID: 27824602
[TBL] [Abstract][Full Text] [Related]
5. Characterization of patients with borderline pulmonary arterial pressure.
Kovacs G; Avian A; Tscherner M; Foris V; Bachmaier G; Olschewski A; Olschewski H
Chest; 2014 Dec; 146(6):1486-1493. PubMed ID: 25451346
[TBL] [Abstract][Full Text] [Related]
6. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.
Maron BA; Brittain EL; Hess E; Waldo SW; Barón AE; Huang S; Goldstein RH; Assad T; Wertheim BM; Alba GA; Leopold JA; Olschewski H; Galiè N; Simonneau G; Kovacs G; Tedford RJ; Humbert M; Choudhary G
Lancet Respir Med; 2020 Sep; 8(9):873-884. PubMed ID: 32730752
[TBL] [Abstract][Full Text] [Related]
8. Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.
Hasler ED; Müller-Mottet S; Furian M; Saxer S; Huber LC; Maggiorini M; Speich R; Bloch KE; Ulrich S
Chest; 2016 Jul; 150(1):57-67. PubMed ID: 26892603
[TBL] [Abstract][Full Text] [Related]
9. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities.
Saggar R; Khanna D; Furst DE; Shapiro S; Maranian P; Belperio JA; Chauhan N; Clements P; Gorn A; Weigt SS; Ross D; Lynch JP; Saggar R
Arthritis Rheum; 2010 Dec; 62(12):3741-50. PubMed ID: 20722025
[TBL] [Abstract][Full Text] [Related]
10. Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis.
Voilliot D; Magne J; Dulgheru R; Kou S; Henri C; Laaraibi S; Sprynger M; Andre B; Pierard LA; Lancellotti P
Int J Cardiol; 2014 May; 173(3):373-9. PubMed ID: 24684997
[TBL] [Abstract][Full Text] [Related]
11. Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure.
Nagel C; Marra AM; Benjamin N; Blank N; Cittadini A; Coghlan G; Distler O; Denton CP; Egenlauf B; Fiehn C; Fischer C; Harutyunova S; Hoeper MM; Lorenz HM; Xanthouli P; Bossone E; Grünig E
Arthritis Rheumatol; 2019 May; 71(5):805-816. PubMed ID: 30615302
[TBL] [Abstract][Full Text] [Related]
12. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
[TBL] [Abstract][Full Text] [Related]
13. Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study.
Gargani L; Pignone A; Agoston G; Moreo A; Capati E; Badano LP; Doveri M; Bazzichi L; Costantino MF; Pavellini A; Pieri F; Musca F; Muraru D; Epis O; Bruschi E; De Chiara B; Perfetto F; Mori F; Parodi O; Sicari R; Bombardieri S; Varga A; Cerinic MM; Bossone E; Picano E
Am Heart J; 2013 Feb; 165(2):200-7. PubMed ID: 23351823
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
Bae S; Saggar R; Bolster MB; Chung L; Csuka ME; Derk C; Domsic R; Fischer A; Frech T; Goldberg A; Hinchcliff M; Hsu V; Hummers L; Schiopu E; Mayes MD; McLaughlin V; Molitor J; Naz N; Furst DE; Maranian P; Steen V; Khanna D
Ann Rheum Dis; 2012 Aug; 71(8):1335-42. PubMed ID: 22307943
[TBL] [Abstract][Full Text] [Related]
15. Cardiac reserve by 6-minute walk stress echocardiography in systemic sclerosis.
Arase M; Kusunose K; Morita S; Yamaguchi N; Hirata Y; Nishio S; Okushi Y; Ise T; Tobiume T; Yamaguchi K; Fukuda D; Yagi S; Yamada H; Soeki T; Wakatsuki T; Sata M
Open Heart; 2021 Feb; 8(1):. PubMed ID: 33608475
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
[TBL] [Abstract][Full Text] [Related]
17. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
18. Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study.
Saggar R; Khanna D; Shapiro S; Furst DE; Maranian P; Clements P; Abtin F; Dua S; Belperio J; Saggar R
Arthritis Rheum; 2012 Dec; 64(12):4072-7. PubMed ID: 22777623
[TBL] [Abstract][Full Text] [Related]
19. Increased pulmonary vascular resistance in early stage systemic hypertension: a resting and exercise stress echocardiography study.
Vriz O; Argiento P; D'Alto M; Ferrara F; Vanderpool R; Naeije R; Bossone E
Can J Cardiol; 2015 Apr; 31(4):537-43. PubMed ID: 25745880
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.
Campo A; Mathai SC; Le Pavec J; Zaiman AL; Hummers LK; Boyce D; Housten T; Champion HC; Lechtzin N; Wigley FM; Girgis RE; Hassoun PM
Am J Respir Crit Care Med; 2010 Jul; 182(2):252-60. PubMed ID: 20339143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
